Tandospirone Citrate in the Treatment of Patients With Generalized Anxiety Disorder

Clinical trial NCT01614041 · COMPLETED

Trial details

NCT number: NCT01614041
Sponsor: Marubeni Pharmaceuticals (Suzhou) Co., Ltd.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Generalized Anxiety Disorder

Start date: 2012-01-10
Primary completion: 2018-09-11
Enrollment: 274

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.